Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Watts

Showing results (271-280 of 341) with videos related to

Pageof 35
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 7, 2008
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronatePaul D Miller, Pierre D Delmas, Robert Lindsay, et al.
Archives of Internal Medicine|July 27, 2005
Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trialGlenn D Braunstein, Dale A Sundwall, Molly Katz, et al.
JAMA|October 20, 1999
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study GroupS T Harris, N B Watts, H K Genant, et al.
JAMA Internal Medicine|May 22, 2023
Race and Ethnicity and Fracture Prediction Among Younger Postmenopausal Women in the Women's Health Initiative StudyCarolyn J Crandall, Joseph C Larson, John T Schousboe, et al.
Journal of the American Geriatrics Society|February 10, 2012
Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal womenSusan L Greenspan, Allison Wyman, Frederick H Hooven, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|October 3, 2002
Standards and guidelines for performing central dual X-ray densitometry from the Canadian panel of International Society for Clinical DensitometryA A Khan, J Brown, K Faulkner, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosisR Rizzoli, S L Greenspan, G Bone, et al.
JAMA|October 2, 2003
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trialJane A Cauley, John Robbins, Zhao Chen, et al.
Poultry Science|April 2, 2024
Evaluating the impact of gypsum as a novel bedding material on broiler performance, foot pad health, and fear responseCesar Escobar, Dexter B Watts, H Allen Torbert, et al.
The American Journal of Medicine|January 16, 1998
Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatmentP D Miller, N B Watts, A A Licata, et al.
Pageof 35

Showing results (271-280 of 341) with videos related to

Sort By:
Pageof 35
The Journal of Clinical Endocrinology and Metabolism|August 7, 2008
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronatePaul D Miller, Pierre D Delmas, Robert Lindsay, et al.
Archives of Internal Medicine|July 27, 2005
Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trialGlenn D Braunstein, Dale A Sundwall, Molly Katz, et al.
JAMA|October 20, 1999
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study GroupS T Harris, N B Watts, H K Genant, et al.
JAMA Internal Medicine|May 22, 2023
Race and Ethnicity and Fracture Prediction Among Younger Postmenopausal Women in the Women's Health Initiative StudyCarolyn J Crandall, Joseph C Larson, John T Schousboe, et al.
Journal of the American Geriatrics Society|February 10, 2012
Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal womenSusan L Greenspan, Allison Wyman, Frederick H Hooven, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|October 3, 2002
Standards and guidelines for performing central dual X-ray densitometry from the Canadian panel of International Society for Clinical DensitometryA A Khan, J Brown, K Faulkner, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosisR Rizzoli, S L Greenspan, G Bone, et al.
JAMA|October 2, 2003
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trialJane A Cauley, John Robbins, Zhao Chen, et al.
Poultry Science|April 2, 2024
Evaluating the impact of gypsum as a novel bedding material on broiler performance, foot pad health, and fear responseCesar Escobar, Dexter B Watts, H Allen Torbert, et al.
The American Journal of Medicine|January 16, 1998
Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatmentP D Miller, N B Watts, A A Licata, et al.
Pageof 35